External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.

Authors : Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S
Year : 2022
Journal : Eur Urol Focus

Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?

Authors : Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T
Year : 2022
Journal : Eur Urol Focus

Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patient

Authors : Diamand R, Albisinni S
Year : 2022
Journal : Eur Urol Focus

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.

Authors : Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R
Year : 2022
Journal : Prostate Cancer Prostatic Dis

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

Authors : Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G
Year : 2022
Journal : Eur Urol Oncol

Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Authors : Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Van Den Bergh RC, Peltier A, Ploussard G
Year : 2022
Journal : Minerva Urol Nephrol

Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systém

Authors : Diamand R, Mjaess G, Ploussard G, Fiard G, Oderda M, Lefebvre Y, Sirtaine N, Roumeguère T, Peltier A, Albisinni S
Year : 2022
Journal : Prog Urol
Volume : 32
Pages : 6S3-6S18

Immature squamous metaplasia of esophageal glands associated with squamous cell carcinoma.

Authors : Verset L, Huberty V, Bourgeois V, Lemmers A, Demetter P
Year : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pages : 396-399

Editorial: Nutrition and the gastrointestinal tract.

Authors : Correia MITD, Van Gossum A
Year : 2022
Journal : Curr Opin Clin Nutr Metab Care
Volume : 25
Pages : 319-320

Ectopic Fetal Liver Tissue in the Placenta of a Twin Pregnancy: A Case Report and Review of Literature.

Authors : Demetter P, Boulay A, Vanden Houte K, Segers V, Verset L
Year : 2022
Journal : Case Rep Pathol
Volume : 2022
Pages : 1966025

Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.

Authors : Gregory J, Tselikas L, Allimant C, De Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M
Year : 2022
Journal : Eur J Nucl Med Mol Imaging

Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.

Authors : Goel S, Tan AR, Rugo HS, Aftimos P, Beelen A, Zhang J, Yi JS, Malik R, OShaughnessy J
Year : 2022
Journal : Future Oncol
Volume : 18
Pages : 3701-3711

Mesenchymal Stem/Stromal Cells as a Therapeutic Tool in Cell-Based Therapy and Regenerative Medicine: An Introduction Expertise to the Topical Collection.

Authors : Merimi M, Fahmi H, De Kock J, Beguin C, Burny A, Moll G, Poggi A, Najar M
Year : 2022
Journal : Cells
Volume : 11

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors : Latacz E, Höppener D, Bohlok A, Leduc S, Tabariès S, Fernández Moro C, Lugassy C, Nyström H, Bozóky B, Floris G, Geyer N, Brodt P, Llado L, Van Mileghem L, De Schepper M, Majeed AW, Lazaris A, Dirix P, Zhang Q, Petrillo SK, Vankerckhove S, Joye I, Meyer Y, Gregorieff A, Roig NR, Vidal-Vanaclocha F, Denis L, Oliveira RC, Metrakos P, Grünhagen DJ, Nagtegaal ID, Mollevi DG, Jarnagin WR, DAngelica MI, Reynolds AR, Doukas M, Desmedt C, Dirix L, Donckier V, Siegel PM, Barnhill R, Gerling M, Verhoef C, Vermeulen PB
Year : 2022
Journal : Br J Cancer
Volume : 127
Pages : 988-1013

Ovarian Clear Cell Carcinoma with Functioning Stroma and Associated Endometrial Intraepithelial Neoplasia.

Authors : Desimpel F, Noël JC, Verset L, Sirtaine N, Buxant F
Year : 2022
Journal : Case Rep Obstet Gynecol
Volume : 2022
Pages : 5538390

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Authors : Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA
Year : 2022
Journal : N Engl J Med
Volume : 387
Pages : 9-20

Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values.

Authors : Paquier Z, Chao SL, Acquisto A, Fenton C, Guiot T, Dhont J, Levillain H, Gulyban A, Bali MA, Reynaert N
Year : 2022
Journal : Biomed Phys Eng Express
Volume : 8

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Authors : Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L
Year : 2022
Journal : Eur J Med Chem
Volume : 242
Pages : 114635

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors : Otmani K, Rouas R, Lewalle P
Year : 2022
Journal : Front Immunol
Volume : 13
Pages : 913951

Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.

Authors : Mjaess G, Karam A, Roumeguère T, Diamand R, Aoun F, McVary K, Moul JW, DE Nunzio C, Albisinni S
Year : 2022
Journal : Prostate Cancer Prostatic Dis